Orchid Pharma Limited (NSE:ORCHPHARMA)
India · Delayed Price · Currency is INR 688.40
-16.70 (-2.37%)
At close: Jan 23, 2026
Orchid Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 524.05 | 996.57 | 921.67 | 463.18 | -19.51 | -1,165 | Upgrade |
Depreciation & Amortization | 348.63 | 343.77 | 321.07 | 547.79 | 869.93 | 1,089 | Upgrade |
Other Amortization | 1.69 | 1.69 | 11.31 | 0.08 | 0.31 | 0.32 | Upgrade |
Loss (Gain) From Sale of Assets | -80.71 | 3.2 | 1.88 | -399.85 | -0 | 0.65 | Upgrade |
Loss (Gain) From Sale of Investments | - | - | - | -0.15 | -5.12 | -19.42 | Upgrade |
Loss (Gain) on Equity Investments | -2.97 | -38.99 | 28.98 | 21.54 | 35.23 | - | Upgrade |
Provision & Write-off of Bad Debts | 71.26 | 68.41 | -2.65 | 11.88 | 36.67 | 13.28 | Upgrade |
Other Operating Activities | -120.55 | -97.17 | 56.05 | 329.54 | 298.27 | 611.43 | Upgrade |
Change in Accounts Receivable | 191.6 | -490.66 | 196.47 | -416.54 | -229.19 | -820.25 | Upgrade |
Change in Inventory | 143.58 | -621.45 | -354.88 | -560.82 | 25.37 | -334.99 | Upgrade |
Change in Accounts Payable | -750.78 | -67.82 | 548.51 | 139.14 | 473.63 | 179.31 | Upgrade |
Change in Other Net Operating Assets | 132.7 | 94.61 | -468.48 | 47.59 | 325.86 | 606.33 | Upgrade |
Operating Cash Flow | 458.52 | 192.15 | 1,260 | 183.38 | 924.75 | 235.86 | Upgrade |
Operating Cash Flow Growth | 211.84% | -84.75% | 587.05% | -80.17% | 292.07% | -70.81% | Upgrade |
Capital Expenditures | -2,680 | -1,501 | -648.15 | -849.13 | -144.04 | -6.04 | Upgrade |
Sale of Property, Plant & Equipment | 89.66 | - | - | 585.46 | 0.99 | 2.86 | Upgrade |
Divestitures | - | - | - | - | 1,594 | - | Upgrade |
Investment in Securities | 1,330 | 1,044 | -2,592 | -53.07 | -326.55 | 668.52 | Upgrade |
Other Investing Activities | 156.55 | 187.39 | 120.02 | 4.61 | 4.88 | 6.71 | Upgrade |
Investing Cash Flow | -1,104 | -269.32 | -3,120 | -312.14 | 1,129 | 672.05 | Upgrade |
Long-Term Debt Issued | - | 285.56 | - | 1,732 | 199.99 | - | Upgrade |
Total Debt Issued | 1,056 | 285.56 | - | 1,732 | 199.99 | - | Upgrade |
Long-Term Debt Repaid | - | -2.21 | -2,200 | -1,098 | -2,048 | -1,251 | Upgrade |
Total Debt Repaid | -2.21 | -2.21 | -2,200 | -1,098 | -2,048 | -1,251 | Upgrade |
Net Debt Issued (Repaid) | 1,054 | 283.35 | -2,200 | 633.92 | -1,848 | -1,251 | Upgrade |
Issuance of Common Stock | - | - | 3,919 | - | - | - | Upgrade |
Other Financing Activities | -32.76 | -31.13 | -48.96 | -322.26 | -320.12 | -399.09 | Upgrade |
Financing Cash Flow | 1,021 | 252.22 | 1,670 | 311.66 | -2,168 | -1,650 | Upgrade |
Net Cash Flow | 376.33 | 175.05 | -189.96 | 182.91 | -113.87 | -741.98 | Upgrade |
Free Cash Flow | -2,221 | -1,309 | 611.77 | -665.75 | 780.71 | 229.82 | Upgrade |
Free Cash Flow Growth | - | - | - | - | 239.71% | -69.98% | Upgrade |
Free Cash Flow Margin | -27.05% | -14.20% | 7.47% | -10.00% | 13.95% | 5.11% | Upgrade |
Free Cash Flow Per Share | -43.78 | -25.81 | 12.65 | -16.31 | 19.13 | 5.63 | Upgrade |
Cash Interest Paid | 32.76 | 31.13 | 48.96 | 322.26 | 320.12 | 399.09 | Upgrade |
Cash Income Tax Paid | - | 9.37 | -6.29 | 2.99 | 19.06 | -49.23 | Upgrade |
Levered Free Cash Flow | -2,683 | -749.27 | -2,498 | -1,048 | 2,206 | 100.7 | Upgrade |
Unlevered Free Cash Flow | -2,592 | -658.4 | -2,396 | -846.73 | 2,406 | 421.55 | Upgrade |
Change in Working Capital | -282.89 | -1,085 | -78.38 | -790.62 | 595.66 | -369.6 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.